FamiCord AG Secures ArThec as New CDMO Client

FamiCord AG has announced a framework agreement with ArThec S.A., expanding its CDMO business. The deal involves developing advanced regenerative medicine technologies, aiming to improve treatments for joint diseases. This collaboration highlights FamiCord's growing strategic focus on CDMO services.

The agreement is projected to generate approximately EUR 0.7 million in revenue within a year, contingent on project progress, and offers an attractive profit margin. This partnership underscores FamiCord's role as a reliable CDMO service provider. CEO Jakub Baran views this as crucial for stabilizing the company's revenue streams and supporting long-term business sustainability.

The collaboration also opens opportunities for future projects in regenerative medicine and advanced therapies. FamiCord continues negotiations with additional potential clients, indicating ongoing expansion in the CDMO sector.